GW Henssler & Associates’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,725	Closed	-$214K	–	242
2023 Q2	$214K	Sell	1,725 -185	-10%	-$24.9K	0.01%	197
2023 Q1	$279K	Sell	1,910 -22	-1%	-$3.25K	0.02%	179
2022 Q4	$308K	Hold	1,932	–	–	0.02%	157
2022 Q3	$258K	Sell	1,932 -70	-3%	-$10.6K	0.02%	166
2022 Q2	$312K	Sell	2,002 -1,201	-37%	-$185K	0.02%	142
2022 Q1	$499K	Buy	3,203 +47	+1%	+$6.82K	0.03%	121
2021 Q4	$402K	Buy	+3,156	New	+$415K	0.03%	164
2021 Q3	–	Sell	-2,831	Closed	-$503K	–	168
2021 Q2	$503K	Sell	2,831 -1	-0%	-$173	0.03%	126
2021 Q1	$465K	Hold	2,832	–	–	0.03%	133
2020 Q4	$467K	Buy	2,832 +18	+0.6%	+$2.68K	0.04%	124
2020 Q3	$401K	Buy	2,814 +185	+7%	+$22.9K	0.03%	125
2020 Q2	$290K	Buy	2,629 +37	+1%	+$4.09K	0.03%	138
2020 Q1	$259K	Sell	2,592 -504	-16%	-$65.2K	0.03%	166
2019 Q4	$462K	Buy	3,096 +396	+15%	+$53.9K	0.04%	142
2019 Q3	$346K	Hold	2,700	–	–	0.03%	150
2019 Q2	$385K	Buy	+2,700	New	+$363K	0.03%	151